Kamada (KMDA) Return on Sales [ROS] (2012 - 2026)
Kamada's Return on Sales [ROS] came in at 17.32% for the quarter ended Jun 30, 2026, up 1.52 percentage points from 15.80% a year earlier and up 1.95 percentage points from the prior quarter.
Kamada (KMDA) Return on Sales [ROS] (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kamada reported Return on Sales [ROS] of 14.51%, down 0.38 percentage points year-over-year; for the year ended Dec 31, 2025, it was 14.54%, up 2.08 percentage points from the prior year.
- Return on Sales [ROS] has increased in each of the last four years, with a five-year change of +0.10 percentage points (years ended Dec 2020 to Dec 2025).
- Going back by year, Return on Sales [ROS] was 12.46% in the year ended Dec 31, 2024 (+5.40 pp), 7.06% in the year ended Dec 31, 2023 (+3.56 pp), 3.50% in the year ended Dec 31, 2022 (+4.18 pp) and -0.67% in the year ended Dec 31, 2021 (-15.11 pp).
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Return on Sales [ROS] since the quarter ended Mar 31, 2025.
- Year-over-year, Return on Sales [ROS] increased in six of the last eight quarters, with an average year-over-year change of +1.77 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in the quarter ended Dec 31, 2022 (a gain of 19.34 percentage points), and the weakest in the quarter ended Sep 30, 2021 (a drop of 25.47 percentage points).
- Business Quant data shows KMDA's Return on Sales [ROS] at 15.37% (quarter ended Mar 31, 2026), 7.95% (quarter ended Dec 31, 2025) and 16.63% (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Kamada | 479.37 Mn | 188.43 Mn | 22.47 Mn | 17.32% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.32% |
| Mar 31, 2026 | 15.37% |
| Dec 31, 2025 | 7.95% |
| Sep 30, 2025 | 16.63% |
| Jun 30, 2025 | 15.80% |
| Mar 31, 2025 | 17.71% |
| Dec 31, 2024 | 13.02% |
| Sep 30, 2024 | 12.68% |
| Jun 30, 2024 | 13.28% |
| Mar 31, 2024 | 10.70% |
| Dec 31, 2023 | 7.62% |
| Sep 30, 2023 | 11.51% |
| Jun 30, 2023 | 7.03% |
| Mar 31, 2023 | 0.94% |
| Dec 31, 2022 | 8.84% |
| Sep 30, 2022 | 7.95% |
| Jun 30, 2022 | -9.72% |
| Mar 31, 2022 | 0.88% |
| Dec 31, 2021 | -10.49% |
| Sep 30, 2021 | -3.49% |
Kamada Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=KMDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "KMDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=KMDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();